+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID07133659

Pilot Study of Lower Starting Dose Avatrombopag for Treatment of Primary Immune Thrombocytopenia ITP

Led by Al-Mustansiriyah University · Updated on 2025-08-21

25

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to explore the safety and effectiveness of a modified lower starting dose of avatrombopag in adults with primary immune thrombocytopenia ITP who need second-line treatment. Avatrombopag, an oral medication that stimulates platelet production, is usually started at 20 mg daily, but this study investigates starting at 20 mg every other day to reduce the common issue of platelet count overshoot. The study is an open-label, single-center pilot trial sponsored by Al-Mustansiriyah University. Participants will begin treatment with avatrombopag 20 mg every other day for one week, followed by dose adjustments based on platelet counts. The study includes three phases dose adjustment, maintenance, and dose tapering with follow-up, lasting up to 24 weeks of treatment. The goal is to assess the response to this lower starting dose and monitor safety, including bleeding complications and quality of life changes. Throughout the study, participants will have platelet levels and other health measures monitored regularly. Researchers will evaluate how quickly and effectively platelet counts respond, the rates of overshoot and treatment failure, and sustained response after stopping treatment at week 52. Safety and quality of life will also be tracked over the year. Overall participation may last up to 52 weeks, including treatment and follow-up phases.

CONDITIONS

Brief Title

Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study

Research Team

A

Alaa Alwan, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here